Skip to content

Clinical trials

Completed Pancreatic Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Completed Country / region: Hong Kong Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20082
20111
20131
20142
20161
20171
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Arbele Pty Ltd1
Boston Scientific Corporation1
Celgene1
NCIC Clinical Trials Group1
NantCell, Inc.1
Orient Europharma Co., Ltd.1
The University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms11
Endocrine Gland Neoplasms2
Liver Neoplasms2
Neoplasms2
Adenocarcinoma1
Breast Neoplasms1
Cholangiocarcinoma1
Colorectal Neoplasms1
Digestive System Diseases1
Digestive System Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.